Janet Huffman
CIK 1866284 · CEO and CFO · last filed 2025-12-15
Janet Huffman is a CEO and CFO who has filed 6 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for OGEN, was dated Dec 15, 2025. Current disclosed insider exposure totals $9.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.3K
2
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | CEO and CFO | 15,000 | $0.62 | $9.3K | $0 | 4 | 2025-12-15 |
| Scienture Holdings, Inc. (MEDS) Delisted | CFO, PAO, PFO | 71,551 | $7.59 | $543.1K | $0 | 2 | 2023-02-24 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-15 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2024-09-20 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2023-08-10 | OGEN | Grant (A) | +15,000 | $0 | EDGAR |
| 2023-03-08 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2023-02-24 | Scienture Holdings, Inc. (MEDS) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2022-09-16 | Scienture Holdings, Inc. (MEDS) Delisted | Grant (A) | +21,551 | $0 | EDGAR |